Bot Chart, page-11234

'Almost a given', but still that element of doubt/risk existed, which has now been 100% removed (i.e. concerning the science). Subsequently it will definitely run up higher than the average 18c it reached, and even higher than the 21c it peaked at, last time we were expecting approval, IMO. But just like last time, I don't expect that movement until only a week or two out of actual decision date. We'll continue to bob around until then I think. The FDA announcement in the near future might get us a cent or two, maybe.

I don't share the NEU comparison either, in the short term (1-2yrs). SB is going to be great, but not as great as within the next 2-4yrs when BOT progresses anti-microbial, rosacea, and acne. I can wait a few years till it hits $5.